国内英语资讯:Xinhua Headlines: European enterprises bullish about growth prospect in China_时事

国内英语资讯:Xinhua Headlines: European enterprises bullish about growth prospect in China

German pharmaceutical company Bayer said in its quarterly report that pharmaceuticals have registered an encouraging sales growth of 5.3 percent to over 4.3 billion euros (4.8 billion dollars) in the first quarter of 2019, "with business in China developing particularly well."

Similarly, Swiss-based biotech company Roche registered a 63 percent pharmaceutical sales growth in China, resulting in a 17-percent year-over-year rise in international sales in the same period.

Meanwhile, the German auto manufacturer BMW Group delivered nearly 2.2 million vehicles to Asia, increasing by 45,000 deliveries on a year-on-year basis, according to its quarterly report.

"This performance was mainly achieved on the back of continued dynamic growth in China, where the BMW Group delivered 1,686,631 BMW, MINI and Rolls-Royce brand vehicles to customers, outperforming the market as a whole with a significant increase of 10.2 percent," said the report.

With a comparable sales growth of 2 percent in the first quarter, a spokesman of Amsterdam-based health technology company Royal Philips told Xinhua that Philips recorded in China a double-digit comparable sales growth in its businesses of "Diagnosis & Treatment" and "Connected Care," adding that it also delivered a double-digit order intake growth there during the period.

POTENTIAL IN ECONOMIC TRANSITION

While downgrading global growth forecasts, the International Monetary Fund in April revised up China's 2019 growth projection by 0.1 percentage point to 6.3 percent.